Facial Treatment Study

Study Number: C25-D101

Study Location:

Dallas Research Center: 1801 N. Glenville Dr., Suite 250 Richardson, Texas 75081

Compensation: Up to $425.00

Gender:

Females

Age:

35-65 years old (up to 70 y/o for dark skin tones and those of Asian race)

Skin Type:

I-VI

Study Description:

This clinical trial is being conducted to evaluate the effectiveness of our advanced facial product in improving common signs of aging. Women participating in the study will use the product daily for 12 weeks.

Study Requirements:

Must
✓ Have Fine lines under eyes, wrinkles in crow’s feet, marionette, and glabella area, lines on the neck and forehead, lack of softness and plumpness on cheeks, and mottled hyperpigmentation (patches of hyperpigmentation) on global face.

Cannot
✕ Have any autoimmune disorders, connective tissue diseases, or immune deficiencies (such as lupus, Crohn’s disease, HIV, or rheumatoid arthritis).

Complete the prescreening survey below:

All information you provide will be kept confidential; you may be contacted by telephone or text. The questions in the survey will be used to determine your eligibility for our studies. If you withdraw or do not qualify, your information will be stored for future reference. You can request to have your information disabled at any time, and we will not contact you for future studies.

Screening Survey

CCPA

Not Applying? Tell Us Why